SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

Eloxx Pharmaceuticals Q3 EPS $(0.32) Beats $(0.39) Estimate

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39) by 17.95 percent.

Benzinga · -

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39) by 17.95 percent.